Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(10%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_1
3
30%
Ph phase_2
2
20%
Ph phase_3
4
40%
Ph phase_4
1
10%

Phase Distribution

3

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
4(40.0%)
Phase 4Post-market surveillance
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(7)

Detailed Status

Completed7
Not yet recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (30.0%)
Phase 22 (20.0%)
Phase 34 (40.0%)
Phase 41 (10.0%)

Trials by Status

recruiting110%
completed770%
not_yet_recruiting220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10